Uncategorised - European Medical Journal

White House

Trump administration cuts more than 90% of USAID funding

The Trump administration is set to cut a total of $60bn in US assistance worldwide, signalling a major shift in health policy.

Microbiome Dynamics Influence Faecal Microbiota Transplantation Efficacy in Ulcerative Colitis

Study reveals gut microbiota families linked to FMT success in ulcerative colitis patients, offering early treatment insights.

Maternal Probiotics May Lower Infant Eczema Risk

Findings suggest that probiotics’ ability to reduce the risk of atopic eczema may not depend on significant changes in gut microbiota.

Elevated Melanoma Risk in Childhood Cancer Survivors

A recent study has revealed that adult survivors of childhood cancer face a significantly elevated risk of developing melanoma, underscoring the necessity for vigilant long-term monitoring and tailored preventive strategies.

Alarming Rise in US Female Physician Suicides

A troubling trend showing female physicians in the United States are dying by suicide at significantly higher rates than their counterparts in the general population has been exposed in a recent cohort study.

Legacy and Innovation: Pivotal Role of Complement in gMG and AQP4-Ab+ NMOSD – A Video Series

First-in-Human Leadless Pacemaker in Left Atrium: A New Frontier in Congenital Heart Pacing

First-in-human helical-fixation leadless pacemaker implantation in the left atrium offers a novel solution for congenital heart disease patients.

The Effects of Classical Music on Pain During Prostate Biopsies

The results showed that the music group experienced significantly less pain, with a median VAS score of 3.6 compared to 5.4.

Optimising Smoking Cessation Within Lung Cancer Screening

Lung cancer screening presents a crucial opportunity to address tobacco dependence, as participation is associated with increased motivation to quit smoking.

SGLT2 Inhibitors Lower Kidney Failure Risk in Advanced Diabetes

A large-scale study in Taiwan has revealed that SGLT2 inhibitors significantly lower the risk of kidney failure in patients with Type 2 diabetes and CKD stage 5.